Tag: Trevena Inc (NASDAQ: TRVN)

Business

Trevena Inc (NASDAQ: TRVN) Begins A Trial To Evaluate OLINVYK Physiological Impact On Respiratory Function In Obese/ Elderly People

by 0 comments

Trevena Inc (NASDAQ: TRVN) commenced a clinical trial evaluating OLINVYK’s physiological impact on respiratory function in obese and elderly subjects.  A leading clinical researcher and professor (Anesthesiology) – Albert Dahan, is leading this evaluation study. It is based on the previously completed work executed by the company in collaboration with Dahan’s […]

Continue Reading →
Business

Trevena Inc (NASDAQ: TRVN) Makes It To The Russell 2000®, Russell 3000®, and Russell Microcap® Indexes And Alto Ingredients Inc (NASDAQ: ALTO) Finds A Place In The Russell 2000® and 3000® Indexes

by 0 comments

Trevena Inc (NASDAQ: TRVN) biopharmaceutical company announced that it had made it to the small-cap Russell 2000® Index, the broad-market Russell 3000® Index, and the Russell Microcap® Index. The respective biopharmaceutical company is involved in creating and commercialization of drugs for individuals suffering from central nervous system (CNS) disorders.  CEO […]

Continue Reading →